Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2022 Sep 7;29:941–942. doi: 10.1016/j.omtn.2022.08.039

lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription

Xue Gong, Tuozhou Dong, Ming Niu, Xiaoshuan Liang, Shanshan Sun, Youxue Zhang, Yue Li ∗∗, Dalin Li
PMCID: PMC9464765  PMID: 36159585

Main text

(Molecular Therapy: Nucleic Acids 21, 804–813; September 2020)

In the originally published version of this article, the authors have discovered an error in Figure 1J. The authors performed preliminary FISH experiments using control probes targeting additional lncRNAs that have been validated in breast cancer cells by previous studies. Images from these experiments were inadvertently included in Figure 1J. The corrected Figure 1 appears below. This correction does not change the conclusion of the paper. The authors regret this error and apologize for any confusion. This error has been changed online.

graphic file with name gr1o.jpg

Figure 1. Identification of LCPAT1 Upregulation in BC Tissues (original)

graphic file with name gr1c.jpg

Figure 1. Identification of LCPAT1 Upregulation in BC Tissues (corrected)

Contributor Information

Yue Li, Email: iyue_0617@163.com.

Dalin Li, Email: dalinli2@sina.com.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES